Quick Answer
INOVIO PHARMACEUTICALS, INC. reported Net Income of -$84.95 million for fiscal year 2025.
INOVIO PHARMACEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$84.95M | +20.8% |
| 2024 | -$107.25M | +20.6% |
| 2023 | -$135.12M | +51.7% |
| 2022 | -$279.82M | +7.9% |
| 2021 | -$303.66M | -82.5% |
| 2020 | -$166.41M | -39.4% |
| 2019 | -$119.36M | -23.1% |
| 2018 | -$96.97M | -9.9% |
| 2017 | -$88.21M | -19.6% |
| 2016 | -$73.74M | -152.6% |
| 2015 | -$29.19M | +19.2% |
| 2014 | -$36.12M | +45.3% |
| 2013 | -$66.03M | -235.7% |
| 2012 | -$19.67M | -29.0% |
| 2011 | -$15.25M | +13.4% |
| 2010 | -$17.61M | +27.8% |
| 2009 | -$24.41M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$45.50M | -80.8% | -93.4% |
| June 30, 2025 | -$23.52M | +27.0% | -19.4% |
| March 31, 2025 | -$19.69M | +35.4% | +21.7% |
| September 30, 2024 | -$25.17M | +25.8% | +21.9% |
| June 30, 2024 | -$32.24M | +9.3% | -5.8% |
| March 31, 2024 | -$30.47M | +25.0% | +10.2% |
| September 30, 2023 | -$33.93M | +10.2% | +4.5% |
| June 30, 2023 | -$35.53M | +67.2% | +12.6% |
- INOVIO PHARMACEUTICALS, INC. showed an increase of +20.8% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, INOVIO PHARMACEUTICALS, INC.’s net income has declined by 248.0% (from -$24.41 million to -$84.95 million).
- The most recent figure is from INOVIO PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: